THANK YOU: Stock the Pantry 2025 Wrap
Getting a glimpse of South Baldwin County from above at the Gulf Coast Hot Air Balloon Festival
WKRG News 5's Akievia McFarland spent the day at the Feeding the Gulf Coast distribution center where loads of food were dropped off to help children in need along the Gulf Coast.
'Rich's loves our communities that we serve and it is a privilege to give back in this way,' Merrill South with Rich's Car Wash said. 'We love to do the toy drive, and this is a way to serve our community here in the summertime.'
Over the course of our month-long Stock the Pantry food drive, we collected thousands of pounds of food, putting a dent in food insecurity.
'One of the amazing things is to see the food go out and get it in the hands of those that need it, but what we know is every morning we need to find more food and put it back out there. And so, absolutely, this event makes a difference in the community,' Feeding the Gulf Coast CEO Michael Ledger said.
Together, we brought in 12,236 pounds of food. That's over 10,000 meals. None of this would be possible without your help and the help of our wonderful sponsors.
In April, they went on shopping sprees and loaded up baskets with snacks and meals that are easy for children to prepare on their own.
Our sponsors feel it's a joy to give back.
'It's the perfect time for it. You know, kids are going to be getting out of school, headed home. They won't have those meals provided by the school system. So I think it's great to be able to give back to the community,' Trey Lambert with Wind Creek Casino and Hotel said.
'To see the scope of this operation and the amount of people that they feed throughout the year, especially with the cause we're helping with during summer, it's incredible,' Palmer's Toyota COO Jacob Palmer said.
International steel company to expand Axis, Alabama, facility
We want to give a big thanks to our sponsors, and you, for giving back to Gulf Coast children during this year's Stock the Pantry.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
If You Bought Only 1 Share of Nvidia at Its IPO, Here's How Many Shares You'd Own Now
Key Points Nvidia's initial public offering (IPO) was on January 22, 1999. The company has executed six stock splits in its 26 years as a public company. Investors who held on to just one share from the IPO would have seen over $85,000 in gains. 10 stocks we like better than Nvidia › Nvidia (NASDAQ: NVDA) has dominated stock market discussion over the past couple years, but it's far from a newcomer. The company was founded on April 5, 1993, and it began trading publicly after its initial public offering (IPO) on January 22, 1999. Had you bought one share of Nvidia stock at its IPO, you would currently have 480 shares, thanks to the six stock splits it has undergone in that time. Stock-Split Date Amount of the Stock Split June 2000 2-for-1 Sept. 2001 2-for-1 April 2006 2-for-1 Sept. 2007 3-for-2 July 2021 4-for-1 June 2024 10-for-1 Data source: Seeking Alpha. How much money would you have made in that time? Although Nvidia has been on the market for a quarter century, it hasn't always been the high-flying stock that investors have seen over the past few years. That said, had you bought one share of Nvidia at its IPO price of $12.00 per share and held on to it all this time, your investment would be worth $85,378 as of this writing. That works out to just under a 40% compound annual growth rate for your position. It's also worth noting that this rate of return doesn't include Nvidia's dividend, which it initiated in Nov. 2012. Anyone who reinvested their dividends would only have boosted their long-term returns. These are mind-boggling results, and Nvidia seems to have plenty left in the tank as it takes center stage in the growth of artificial intelligence. Do the experts think Nvidia is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Nvidia make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,019% vs. just 178% for the S&P — that is beating the market by 841.12%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Stefon Walters has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy. If You Bought Only 1 Share of Nvidia at Its IPO, Here's How Many Shares You'd Own Now was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
Ball (NYSE:BALL) Will Pay A Dividend Of $0.20
The board of Ball Corporation (NYSE:BALL) has announced that it will pay a dividend of $0.20 per share on the 16th of September. Including this payment, the dividend yield on the stock will be 1.4%, which is a modest boost for shareholders' returns. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Ball's Projected Earnings Seem Likely To Cover Future Distributions The dividend yield is a little bit low, but sustainability of the payments is also an important part of evaluating an income stock. Prior to this announcement, Ball was quite comfortably covering its dividend with earnings and it was paying more than 75% of its free cash flow to shareholders. The company is clearly earning enough to pay this type of dividend, but it is definitely focused on returning cash to shareholders, rather than growing the business. Looking forward, earnings per share is forecast to rise by 135.1% over the next year. Assuming the dividend continues along recent trends, we think the payout ratio could be 20% by next year, which is in a pretty sustainable range. Check out our latest analysis for Ball Ball Has A Solid Track Record Even over a long history of paying dividends, the company's distributions have been remarkably stable. The annual payment during the last 10 years was $0.26 in 2015, and the most recent fiscal year payment was $0.80. This means that it has been growing its distributions at 12% per annum over that time. We can see that payments have shown some very nice upward momentum without faltering, which provides some reassurance that future payments will also be reliable. Ball Could Grow Its Dividend Investors could be attracted to the stock based on the quality of its payment history. Ball has seen EPS rising for the last five years, at 5.8% per annum. Shareholders are getting plenty of the earnings returned to them, which combined with strong growth makes this quite appealing. Our Thoughts On Ball's Dividend Overall, it's nice to see a consistent dividend payment, but we think that longer term, the current level of payment might be unsustainable. While Ball is earning enough to cover the dividend, we are generally unimpressed with its future prospects. We would be a touch cautious of relying on this stock primarily for the dividend income. It's important to note that companies having a consistent dividend policy will generate greater investor confidence than those having an erratic one. Still, investors need to consider a host of other factors, apart from dividend payments, when analysing a company. Case in point: We've spotted 2 warning signs for Ball (of which 1 shouldn't be ignored!) you should know about. If you are a dividend investor, you might also want to look at our curated list of high yield dividend stocks. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
5 hours ago
- Yahoo
With 65% institutional ownership, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is a favorite amongst the big guns
Key Insights Given the large stake in the stock by institutions, Rigel Pharmaceuticals' stock price might be vulnerable to their trading decisions 51% of the business is held by the top 9 shareholders Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. To get a sense of who is truly in control of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), it is important to understand the ownership structure of the business. With 65% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute. Let's take a closer look to see what the different types of shareholders can tell us about Rigel Pharmaceuticals. Check out our latest analysis for Rigel Pharmaceuticals What Does The Institutional Ownership Tell Us About Rigel Pharmaceuticals? Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. We can see that Rigel Pharmaceuticals does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Rigel Pharmaceuticals' earnings history below. Of course, the future is what really matters. Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. It would appear that 15% of Rigel Pharmaceuticals shares are controlled by hedge funds. That's interesting, because hedge funds can be quite active and activist. Many look for medium term catalysts that will drive the share price higher. Our data shows that BlackRock, Inc. is the largest shareholder with 9.7% of shares outstanding. Armistice Capital LLC is the second largest shareholder owning 8.5% of common stock, and Morgan Stanley, Investment Banking and Brokerage Investments holds about 8.3% of the company stock. Furthermore, CEO Raul Rodriguez is the owner of 0.8% of the company's shares. We did some more digging and found that 9 of the top shareholders account for roughly 51% of the register, implying that along with larger shareholders, there are a few smaller shareholders, thereby balancing out each others interests somewhat. While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future. Insider Ownership Of Rigel Pharmaceuticals While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. Shareholders would probably be interested to learn that insiders own shares in Rigel Pharmaceuticals, Inc.. As individuals, the insiders collectively own US$5.5m worth of the US$392m company. Some would say this shows alignment of interests between shareholders and the board. But it might be worth checking if those insiders have been selling. General Public Ownership With a 19% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Rigel Pharmaceuticals. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders. Next Steps: It's always worth thinking about the different groups who own shares in a company. But to understand Rigel Pharmaceuticals better, we need to consider many other factors. For example, we've discovered 1 warning sign for Rigel Pharmaceuticals that you should be aware of before investing here. If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
